Membrane orientation of carboxyl-terminal half P-glycoprotein: Topogenesis of transmembrane segments

European Journal of Cell Biology

Volumn 78, Issue 9, 1999, Pages 624-631

  Han, Ernest S ^a   Zhang, Jian Ting ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

In vitro expression; MDR; P glycoprotein; Topogenesis; Topology

Indexed keywords

GLYCOPROTEIN P; MEMBRANE PROTEIN;

ARTICLE; CELL FREE SYSTEM; CELL MEMBRANE TRANSPORT; CYTOPLASM; ENDOPLASMIC RETICULUM; NONHUMAN; ORIENTATION; PRIORITY JOURNAL;

EID: 0032821676     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-9335(99)80047-8     Document Type: Article

References (38)

1. Beja, O., E. Bibi (1995): Multidrug resistance protein (Mdr)-alkaline phosphatase hybrids in Escherichia coli suggest a major revision in the topology of the C-terminal half of Mdr. J. Biol. Chem. 270, 12351-12354.
2. Bibi, E., O. Beja (1994): Membrane topology of multidrug resistance protein expressed in Escherichia coli. N-terminal domain. J. Biol. Chem. 269, 19910-19915.
3. Borel, A. C., S. M. Simon (1996): Biogenesis of polytopic membrane proteins: membrane segments assemble within translocation channels prior to membrane integration. Cell 85, 379-389.
4. Chen, C. J., J. E. Chin, K. Ueda, D. P. Clark, I. Pastan, M. M. Gottesman, I. B. Roninson (1986): Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47, 381-389.
5. Chen, H., D. A. Kendall (1995): Artificial transmembrane segments. Requirements for stop transfer and polypeptide orientation. J. Biol. Chem. 270, 14115-14122.
6. Cianfriglia, M., F. Poloni, C. Signoretti, G. Romagnoli, M. Tombesi, F. Felici (1996): Topology of MDR1-P-glycoprotein as indicated by epitope mapping of monoclonal antibodies to human MDR cells. Cytotechnology 19, 247-251.
7. Gafvelin, G., G. von Heijne (1994): Topological "frustration" in multispanning E. coli inner membrane proteins. Cell 77, 401-412.
8. Georges, E., T. Tsuruo, V. Ling (1993): Topology of P-glycoprotein as determined by epitope mapping of MRK-16 monoclonal antibody. J. Biol. Chem. 268, 1792-1798.
9. Germann, U. A., I. Pastan, M. M. Gottesman (1993): P-glycoproteins: mediators of multidrug resistance. Semin. Cell Biol. 4, 63-76.
10. Gros, P., J. Croop, D. Housman (1986): Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47, 371-380.
11. Han, E. S., J. T. Zhang (1988): Mechanism involved in generating the carboxyl-terminal half topology of P-glycoprotein. Biochemistry 37, 11996-12004.
12. Hardy, S. P., M. A. Valverde, H. R. Goodfellow, C. F. Higgins, F. V. Sepulveda (1994): Regulation of volume-activated chloride channels by protein kinase C-mediated phosphorylation of P-glycoprotein. Jpn. J. Physiol. 44 Suppl. 2, S9-15.
13. Hartmann, E., T. A. Rapoport, H. F. Lodish (1989): Predicting the orientation of eukaryotic membrane-spanning proteins. Proc. Natl. Acad. Sci. USA 86, 5786-5790.
14. Hegde, R. S., V. R. Lingappa (1997): Membrane protein biogenesis: regulated complexity at the endoplasmic reticulum. Cell 91, 575-582.
15. Kast, C., V. Canfield, R. Levenson, P. Gros (1995): Membrane topology of P-glycoprotein as determined by epitope insertion: transmembrane organization of the N-terminal domain of mdr3. Biochemistry 34, 4402-4411.
16. Kast, C., V. Canfield, R. Levenson, P. Gros (1996): Transmembrane organization of mouse P-glycoprotein determined by epitope insertion and immunofluorescence. J. Biol. Chem. 271, 9240-9248.
17. Knight, B. C., S. High (1998): Membrane integration of Sec61alpha: a core component of the endoplasmic reticulum translocation complex. Biochem. J. 331, 161-167.
18. Liao, S., J. Lin, H. Do, A. E. Johnson (1997): Both lumenal and cytosolic gating of the aqueous ER translocon pore are regulated from inside the ribosome during membrane protein integration. Cell 90, 31-41.
19. Loo, T. W., D. M. Clarke (1995): Membrane topology of a cysteineless mutant of human P-glycoprotein. J. Biol. Chem. 270, 843-848.
20. Moss, K., A. Helm, Y. Lu, A. Bragin, W. R. Skach (1998): Coupled translocation events generate topological heterogeneity at the endoplasmic reticulum membrane. Mol. Biol. Cell 9, 2681-2697.
21. Nilsson, I. M., G. von Heijne (1993): Determination of the distance between the oligosaccharyltransferase active site and the endoplasmic reticulum membrane. J. Biol. Chem. 268, 5798-5801.
22. Poloni, F., S. Palumbo, M. Cianfriglia, F. Felici (1995a): Selection of phage-displayed peptides mimicking an extracellular epitope of human MDR1-P-glycoprotein. Physiol. Chem. Phys. Med. NMR 27, 271-280
23. Poloni, F., G. Romagnoli, M. Cianfriglia, F. Felici (1995b): Isolation of antigenic mimics of MDR1-P-glycoprotein by phage-displayed peptide libraries. Int. J. Cancer 61, 727-731.
24. Rosenberg, M. F., R. Callaghan, R. C. Ford, C. F. Higgins (1997): Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis. J. Biol. Chem. 272, 10685-10694.
25. Saaf, A., E. Wallin, G. von Heijne (1998): Stop-transfer function of pseudo-random amino acid segments during translocation across prokaryotic and eukaryotic membranes. Eur. J. Biochem. 251, 821-829.
26. Sato, K., H. Mori, M. Yoshida, M. Tagaya, S. Mizushima (1997): In vitro analysis of the stop-transfer process during translocation across the cytoplasmic membrane of Escherichia coli. J. Biol. Chem. 272, 20082-20087.
27. Schinkel, A. H., S. Kemp, M. Dolle, G. Rudenko, E. Wagenaar (1993): N-glycosylation and deletion mutants of the human MDR1 P-glycoprotein. J. Biol. Chem. 268, 7474-7481.
28. Sharom, F. J. (1997): The P-glycoprotein efflux pump: how does it transport drugs? J. Membr. Biol. 160, 161-175.
29. Skach, W. R., M. C. Calayag, V. R. Lingappa (1993): Evidence for an alternate model of human P-glycoprotein structure and biogenesis. J. Biol. Chem. 268, 6903-6908.
30. Ueda, K., Y. Taguchi, M. Morishima (1997): How does P-glycoprotein recognize its substrates? Semin. Cancer Biol. 8, 151-159.
31. Vanoye, C. G., G. A. Altenberg, L. Reus (1997): P-glycoprotein is not a swelling-activated Cl-channel; possible role as a Cl-channel regulator. J. Physiol. 502, 249-258.
32. Wang, G., R. Pincheira, M. Zhang, J. T. Zhang (1997): Conformational changes of P-glycoprotein by nucleotide binding. Biochem. J. 328, 897-904.
33. Yoshimura, A., Y. Kuwazuru, T. Sumizawa, M. Ichikawa, S. Ikeda, T. Uda, S. Akiyama (1989): Cytoplasmic orientation and two-domain structure of the multidrug transporter, P-glycoprotein, demonstrated with sequence-specific antibodies. J. Biol. Chem. 264, 16282-16291.
34. Zhang, J. T. (1996): Sequence requirements for membrane assembly of polytopic membrane proteins: molecular dissection of the membrane insertion process and topogenesis of the human MDR3 P-glycoprotein. Mol. Biol. Cell 7, 1709-1721.
35. Zhang, J. T., M. Duthie, V. Ling (1993): Membrane topology of the N-terminal half of the hamster P-glycoprotein molecule. J. Biol. Chem. 268, 15101-15110.
36. Zhang, J. T., V. Ling (1991): Study of membrane orientation and glycosylated extracellular loops of mouse P-glycoprotein by in vitro translation. J. Biol. Chem. 266, 18224-18232.
37. Zhang, J. T., V. Ling (1993): Membrane orientation of transmembrane segments 11 and 12 of MDR- and non-MDR-associated P-glycoproteins. Biochim. Biophys. Acta 1153, 191-202.
38. Zhang, M., G. Wang, A. Shapiro, J.T. Zhang (1996): Topological folding and proteolysis profile of P-glycoprotein in membranes of multidrug-resistant cells: implications for the drug-transport mechanism. Biochemistry 35, 9728-9736.